These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12114217)

  • 21. Anti-tumour activity of interferon-alpha in multiple myeloma: role of interleukin 6 and tumor cell differentiation.
    Matsui W; Huff CA; Vala M; Barber J; Smith BD; Jones RJ
    Br J Haematol; 2003 Apr; 121(2):251-8. PubMed ID: 12694246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
    Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
    Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: dose and time scheduling dependency.
    van der Hem KG; Schuurhuis GJ; Dräger AM; Odding JH; Huijgens PC
    Leuk Res; 1996 Sep; 20(9):743-50. PubMed ID: 8947584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
    La Rosée P; Jia T; Demehri S; Härtel N; de Vries P; Bonham L; Hollenback D; Singer JW; Melo JV; Druker BJ; Deininger MW
    Clin Cancer Res; 2006 Nov; 12(21):6540-6. PubMed ID: 17085669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cells.
    van der Hem KG; Dräger AM; Odding JH; Langenhuijsen MM; Huijgens PC
    Leuk Res; 1995 Jan; 19(1):7-13. PubMed ID: 7837820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
    Sur P; Nandi N; Ghosh P; Ghosh NC
    Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanosine 5'-triphosphate induces differentiation-dependent apoptosis in human leukemia U937 and KG1 cells.
    Yazdanparast R; Moosavi MA; Mahdavi M; Lotfi A
    Acta Pharmacol Sin; 2006 Sep; 27(9):1175-84. PubMed ID: 16923338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.
    Angstreich GR; Matsui W; Huff CA; Vala MS; Barber J; Hawkins AL; Griffin CA; Smith BD; Jones RJ
    Br J Haematol; 2005 Aug; 130(3):373-81. PubMed ID: 16042686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the growth-inhibitory and apoptosis-inducing activities of a triterpene saponin, securioside B against BAC1.2F5 macrophages.
    Yui S; Kudo T; Hodono K; Mimaki Y; Kuroda M; Sashida Y; Yamazaki M
    Mediators Inflamm; 2003 Jun; 12(3):157-66. PubMed ID: 12857599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2F-6 suppresses growth-associated apoptosis of human hematopoietic progenitor cells by counteracting proapoptotic activity of E2F-1.
    Kikuchi J; Shimizu R; Wada T; Ando H; Nakamura M; Ozawa K; Furukawa Y
    Stem Cells; 2007 Oct; 25(10):2439-47. PubMed ID: 17600109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism.
    De Lorenzo MS; Yamaguchi K; Subbaramaiah K; Dannenberg AJ
    Clin Cancer Res; 2003 Oct; 9(13):5036-43. PubMed ID: 14581379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
    Zauli G; Rimondi E; Celeghini C; Milani D; Secchiero P
    J Cell Physiol; 2010 Feb; 222(2):357-64. PubMed ID: 19877156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia.
    Fiegl M; Juergens M; Hiddemann W; Braess J
    Leuk Res; 2007 Apr; 31(4):531-9. PubMed ID: 16939689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
    Mohammad RM; al-Katib A; Pettit GR; Sensenbrenner LL
    Leuk Res; 1993 Jan; 17(1):1-8. PubMed ID: 8429674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.